HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Richard W James Selected Research

Coronary Disease (Coronary Heart Disease)

11/2011Effects of paraoxonase activity and gene polymorphism on coronary vasomotion.
6/2005Paraoxonase-1 promoter polymorphism C--107T and serum apolipoprotein AI interact to modulate serum paraoxonase-1 status.
6/2003A helping hand for the good guy; novel pharmacological approaches for augmenting the cardiovascular benefits of high density lipoproteins.
9/2002Kinetics of HDL cholesterol and paraoxonase activity in moderate alcohol consumers.
3/2002Paraoxonase-1 L55M polymorphism is associated with an abnormal oral glucose tolerance test and differentiates high risk coronary disease families.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Richard W James Research Topics

Disease

10Atherosclerosis
09/2019 - 02/2003
10Cardiovascular Diseases (Cardiovascular Disease)
09/2019 - 06/2003
5Reperfusion Injury
01/2019 - 04/2012
5Type 2 Diabetes Mellitus (MODY)
01/2017 - 03/2008
5Coronary Disease (Coronary Heart Disease)
11/2011 - 03/2002
4Inflammation (Inflammations)
09/2019 - 06/2005
4Metabolic Syndrome (Dysmetabolic Syndrome X)
01/2019 - 04/2005
4Infarction (Infarctions)
01/2019 - 05/2013
4Hypertension (High Blood Pressure)
01/2017 - 06/2006
4Vascular Diseases (Vascular Disease)
01/2014 - 04/2002
3Myocardial Infarction
01/2019 - 03/2012
2Chronic Renal Insufficiency
07/2019 - 02/2018
2Ischemia
05/2013 - 04/2012
2Wounds and Injuries (Trauma)
04/2012 - 01/2006
2Obesity
05/2008 - 03/2008
2Coronary Artery Disease (Coronary Atherosclerosis)
06/2006 - 04/2005
2Poisoning
01/2006 - 11/2004
2Hypercholesterolemia
09/2005 - 08/2005
2Atherosclerotic Plaque (Atheroma)
02/2004 - 02/2003
1Non-alcoholic Fatty Liver Disease
01/2019
1Hypoxia (Hypoxemia)
01/2019
1Fatty Liver
01/2019
1Abdominal Obesity
01/2019
1Chronic Kidney Failure (Chronic Renal Failure)
02/2018
1Heart Diseases (Heart Disease)
01/2018
1Diabetes Mellitus
01/2016
1Dyslipidemias (Dyslipidemia)
01/2016
1Myocardial Ischemia (Ischemic Heart Diseases)
01/2016
1Necrosis
03/2011
1Heart Failure
03/2011
1Herpes Zoster
11/2010
1Neoplasms (Cancer)
01/2010
1Insulin Resistance
05/2008
1Familial Combined Hyperlipidemia (Combined Hyperlipidemia, Familial)
02/2004

Drug/Important Bio-Agent (IBA)

17Aryldialkylphosphatase (Paraoxonase)IBA
09/2019 - 03/2002
11EnzymesIBA
09/2019 - 03/2002
11HDL CholesterolIBA
09/2019 - 09/2002
10HDL LipoproteinsIBA
01/2019 - 02/2004
6AntioxidantsIBA
01/2017 - 03/2002
6Lipoproteins (Lipoprotein)IBA
01/2016 - 02/2004
5LDL Lipoproteins (beta Lipoproteins)IBA
09/2019 - 11/2004
5Apolipoprotein A-I (Apolipoprotein A1)IBA
01/2018 - 04/2005
4ApolipoproteinsIBA
01/2018 - 04/2005
4CholesterolIBA
04/2012 - 02/2003
4oxidized low density lipoproteinIBA
11/2011 - 11/2004
4Glucose (Dextrose)FDA LinkGeneric
05/2008 - 03/2002
4LDL CholesterolIBA
03/2008 - 04/2005
3Proteins (Proteins, Gene)FDA Link
07/2019 - 05/2012
3Triglycerides (Triacylglycerol)IBA
01/2019 - 04/2007
3sphingosine 1-phosphate (sphingosine-1-phosphate)IBA
02/2018 - 01/2016
3LipidsIBA
01/2018 - 06/2003
3p38 Mitogen-Activated Protein KinasesIBA
01/2006 - 12/2003
2CytokinesIBA
02/2018 - 03/2011
2arylesteraseIBA
01/2017 - 01/2017
2ConnexinsIBA
03/2016 - 05/2012
2Connexin 43 (Connexin43)IBA
03/2016 - 02/2003
2Apolipoproteins E (ApoE)IBA
09/2015 - 06/2005
2CollagenIBA
02/2004 - 02/2003
1C-Reactive ProteinIBA
09/2019
1salicylhydroxamic acid (SHAM)IBA
01/2019
1MicroRNAs (MicroRNA)IBA
01/2019
1AlbuminsIBA
02/2018
1DNA (Deoxyribonucleic Acid)IBA
01/2018
1Thyrotropin (Thyroid-Stimulating Hormone)FDA Link
01/2018
1EsterasesIBA
01/2017
1Alanine (L-Alanine)FDA Link
03/2016
1Troponin IIBA
03/2016
1ATP-Binding Cassette Transporters (ABC Transporters)IBA
01/2016
1Interleukin-33IBA
09/2015
1Phospholipids (Phosphatides)FDA LinkGeneric
01/2015
11- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA
05/2013
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
04/2012
1STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA
04/2012
1AutoantibodiesIBA
03/2012
1AldosteroneIBA
03/2012
1A-factor (Streptomyces)IBA
11/2011
1Adenosine (Adenocard)FDA LinkGeneric
11/2011
12- cyclohexylidenhydrazo- 4- phenyl- thiazoleIBA
11/2011
1Interleukin-6 (Interleukin 6)IBA
03/2011
1Phosphotransferases (Kinase)IBA
11/2010
1CD36 AntigensIBA
11/2010
1CarbohydratesIBA
09/2010
1Doxorubicin (Adriamycin)FDA LinkGeneric
01/2010
1Insulin (Novolin)FDA Link
05/2008
1Phytoestrogens (Phytoestrogen)IBA
05/2008
1Apolipoproteins B (ApoB)IBA
04/2007
1Interleukin-8 (Interleukin 8)IBA
01/2006
1OrganophosphatesIBA
01/2006
1Protein Kinases (Protein Kinase)IBA
09/2005
1Interleukin-1 Receptors (Interleukin 1 Receptor)IBA
06/2005
1InterleukinsIBA
06/2005
1Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link
06/2005
1Interleukin-1 (Interleukin 1)IBA
06/2005
1Chemokine ReceptorsIBA
02/2004
1CC ChemokinesIBA
02/2004
1Chemokine CCL5IBA
02/2004
1ChemokinesIBA
02/2004
1Met- RANTESIBA
02/2004
1HDL2 LipoproteinsIBA
02/2004

Therapy/Procedure

1Catheter Ablation
01/2018